India is increasing petrochemical feedstock supplies to pharmaceutical manufacturers to protect essential medicine availability amid West Asia supply-chain disruptions. Refiners are now pushing key inputs such as propylene, ammonia and methanol, while customs duties have been reduced to lower landed costs. As a result, domestic drug prices are holding steady.
A war-linked pharma cost shock is now rippling into India’s healthcare market. Vizag chemists say paracetamol and other essential generics may see hikes of 30–40% as manufacturers face surging raw material prices, especially from West Asia. Current supplies are said to be stable, but future revisions could raise retail bills. The government is working to curb volatility and maintain availability.
Your news, in seconds
Get the Beige app — every story in 60 words, updated hourly. Free on iOS & Android.
Swipe through stories, personalise your feed, and save articles for later — all on the app.
